Skip to main content

Fatigue clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • HBS-301 in Participants With Narcolepsy

    open to eligible people ages 18 years and up

    This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-301 in treating excessive daytime sleepiness (EDS), cataplexy, sleepiness/wakefulness, and fatigue in adult participants (ages ≥18 years) with narcolepsy.

    at UCSF

  • Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 21-85

    Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability. The proposed project will use precise in vivo tools to study the pathophysiology of poor physical endurance in a clinical trial treating metabolic acidosis among persons living with chronic kidney disease.

    at UC Davis

Our lead scientists for Fatigue research studies include .

Last updated: